Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarkers in amyotrophic lateral sclerosis.

The Lancet. Neurology - 1 Jan 2009

Turner Martin R, Kiernan Matthew C, Leigh P Nigel, Talbot Kevin

Abstract excerpt

Amyotrophic lateral sclerosis (ALS; motor neuron disease) is a relentlessly progressive disorder. After half a century of trials, only one drug with modest disease-modifying potency--riluzole--has been developed. The diagnosis of this disorder is still clinical and there is a pronounced delay bet...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis
Share to Biomarkers
Share to Brain Chemistry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Magnetic Resonance Imaging

Share to Magnetic Resonance Spectroscopy

Share to Phenotype

Source

Identifiers

PMID: 19081518
DOI: 10.1016/S1474-4422(08)70293-X

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19081518-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarkers in amyotrophic lateral sclerosis.PMID 19081518Read ↗

Diagnosis, pathogenesis and therapeutic targets in amyotrophic lateral sclerosis.Semantic proximity Read ↗

Biomarkers for amyotrophic lateral sclerosis.Semantic proximity Read ↗

Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applicationsSemantic proximity Read ↗

Mechanisms, models and biomarkers in amyotrophic lateral sclerosisSemantic proximity Read ↗

Ensuring continued progress in biomarkers for amyotrophic lateral sclerosisSemantic proximity Read ↗

Biomarkers in Motor Neuron Disease: A State of the Art ReviewSemantic proximity Read ↗

Amyotrophic lateral sclerosis.Semantic proximity Read ↗

Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis.Semantic proximity Read ↗

Amyotrophic lateral sclerosis.Semantic proximity Read ↗

MicroRNAs as Biomarkers in Amyotrophic Lateral SclerosisSemantic proximity Read ↗

Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis DiagnosisSemantic proximity Read ↗

Prognostic Clinical and Biological Markers for Amyotrophic Lateral Sclerosis Disease Progression: Validation and Implications for Clinical Trial Design and AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.